SEI Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
RI
JT
ACA
PC
SEI Investments's MDGL Position: Q2 2026 in Review
SEI Investments increased its Madrigal Pharmaceuticals (MDGL) stake by 6.7% in Q2 2026, buying an estimated $834K and bringing the position to 25,826 shares worth $13.9M. The position accounts for 0.01% of the portfolio, ranked #971.
SEI Investments first reported a position in MDGL in Q2 2018 and has held it in 22 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.
- SEI Investments held 25,826 shares of Madrigal Pharmaceuticals worth $13.9M as of Q2 2026.
- SEI Investments bought 1,628 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $834K.
- Madrigal Pharmaceuticals made up 0.01% of SEI Investments's portfolio in Q2 2026, its #971 holding.
- SEI Investments first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 22 quarters since.
- 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.